DURHAM, N.C.–(BUSINESS WIRE)–December 9, 2020 — Mycovia Pharmaceuticals, Inc. (“Mycovia”),
Poliovirus therapy shows potential as cancer vaccine in lab studies
A modified form of poliovirus, pioneered at Duke Cancer Institute
Latest studies suggest a possible downturn in rate of new cases of diabetes
While overall, the numbers (prevalence) of people with type 2
Studies uncover new approaches to combat hair loss in men and women
Two recent studies highlight novel ways to combat pattern hair
Body parts respond to day and night independently from brain, studies show
Can your liver sense when you’re staring at a television
Studies expand and update an encyclopedia of cancer cell lines
Large libraries of cancer cell lines—collections of cells that represent
Monthly shots control HIV as well as pills in two big studies
Monthly shots of HIV drugs worked as well as daily
Poor whites bear the brunt of U.S. opioid crisis, studies find
(HealthDay)—America’s ongoing opioid epidemic has struck poor whites harder than
Studies showed that These cholesterol-destroy countersink the valuable brown grease
Cholesterol lowering drugs: statins reduce brown adipose tissue The ingestion
Lab studies the science of picky eating
As any parent will tell you, there is an art